European AIDS Treatment Group

EU Civil Society Forum (CSF) on HIV , TB and Hepatitis
EU Civil Society Forum on Drugs
WHO Regional Coordination Committee on HIV, TB and Hep
AIDS Action Europe;
European Public Health Alliance (EPHA);
European Forum for Good Clinical Practice (EFGCP)
European Patient Forum (EPF)
Platform for Cooperation with undocumented migrants (PICUM)
ILGA – Europe
PHILEA - Philanthropy Europe Association
ESWA - European Sex Workers Rights Alliance

None declared

Promotes their own interests or the collective interests of their members

Jan 2022 - Dec 2022

25,000€ - 49,999€

None declared

25,000€ - 49,999€

None declared

Commission expert group - Civil Society Forum on Drugs#E02681#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2681 #Member #C#Civil society

LGTBI#EU Civil Society Forum on Drugs

EU Civil Society forum on HIV, TB and Hepatitis coordination with AAE, EHRA, Correlations, TBEC. EATG acts as secretariat together with AAE.
EUHPP thematic network on HIV, TB and Hep coordination with the CSF.
Pan-European Mental Health Coalition: To address these gaps in mental health services and support, many of which have been made worse by the COVID-19 pandemic, WHO/Europe has launched a new Pan-European Mental Health Coalition.
The Glasgow Manifesto of the International Coalition of Older People with HIV (iCOPe HIV): It has been launched on Glasgow HIV conference in October 2022 and has been endorsed by more than 120 organisations. iCOPe HIV is an initiative of the four founding partners EATG (Europe), NATAP (USA), Realize (Canada) and UTOPIA_BXL (Belgium).
EHVA: This project Project aims: To develop a Multidisciplinary Vaccine Platform (MVP) in the fields of prophylactic and therapeutic HIV vaccines.
RBDCOV - RBD Dimer recombinant protein vaccine against SARSCoV2
EU-PEARL – EU Patient-Centric Clinical Trial Platform
EATRIS+ - Flagship in Personalised Medicines
Project CORE – “Community Response to End Inequalities” (2023_2025) aims to reduce these inequalities by promoting, strengthening and integrating the community responses that have proven key in reaching those not yet connected to prevention and healthcare services, especially in MSs where these responses are still lacking.
The Strategic Community HIV Prevention Empowerment – SCOPE - project aims to strengthen community engagement at local and regional levels to reduce the gap in access and use of HIV combination prevention interventions by populations that are most affected by HIV, but which remain inadequately served by the health system and which are underrepresented in policy and public debate.
Project PROMise: The overall goal of the project is to establish a guidance document and recommendations for the consideration of HIV-specific Patient Reported Outcome Measures (PROMs) in HIV R&D in collaboration with key stakeholders from community organisations, academia, industry, regulators and Health Technology Assessment (HTA) bodies.
Project BELONG: The overall goal of this advocacy project is to produce a position paper that advocates for the inclusion of people living with (as suggested by the FDA) HIV in clinical research to be mirrored by European countries and regulated by the EMA, not only for cancer trials, but also for other disease areas.
From March 2020 to January 2021, EATG documented the impact of the disruption caused by the ShapeSARS-COV2 pandemic on people living with or most affected by HIV and solutions found to mitigate it, including at community level. EATG published 6 bulletins, organised mutual learning e-meetings on HIV self-testing, ensuring continuity in sexual health services, COVID-19 vaccines, adaptation of services at community level: https://linktr.ee/eatgcovid19
The HIV and Mental Health project aimed to explore the existing knowledge about the interplay of mental health, well-being and HIV and translate it into practical recommendations for both community organisations and healthcare professionals in the European context.
40 years of HIV/AIDS: Stigma & Discrimination and the impact on Mental Health: https://www.eatg.org/campaigns/wad-2021-40-years-of-hiv-aids-stigma-discrimination-and-the- impact-on-mental-health/
30 years EATG: As part of its 30-year celebrations, EATG launched on World AIDS Day 2022 a publication, ‘Celebrating 30 years of HIV Activism: Stories from The Frontline’:
EATG, together with ECDC and AAE coordinated and launched the first ever European-wide HIV stigma survey.
HIV and eHealth: Opportunities and Challenges for People Living with and Affected by HIV:
EATG endorses a series of letters and statements touching upon EU policies on health, access, funding, human rights etc.

None declared

2 meetings found. Download meetings

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

• Date	22 Jul 2019	Location	Brussels
  Subject	Access to medicines
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Alina Timofte (Cabinet member) Arunas Vinciunas (Cabinet member) Vytenis Andriukaitis (Commissioner)
  Other Lobbyists	The European Association of Hospital Pharmacists Association Belge des Consommateurs Test-Achats / Belgische Verbruikersunie Test-Aankoop

• Date	28 Nov 2016	Location	Brussels
  Subject	EU and NGOs action on HIV, TB and Hepatitis
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Paula Duarte Gaspar (Cabinet member) Vytenis Andriukaitis (Commissioner)
  Other Lobbyists	European Liver Patients' Association Deutsche Aidshilfe GLOBAL HEALTH ADVOCATES